Early plasmapheresis in type 2 benign recurrent intrahepatic cholestasis: A case report and review of literature
Plasmapheresis is a safe and effective option for therapy-refractory BRIC type 2, particularly when initiated early in cholestasis.
Authors
- Anja M. Geerts (ORCID: https://orcid.org/0000-0002-2218-9081)
- Xavier Verhelst (ORCID: https://orcid.org/0000-0002-2798-5415)
- Annemieke Dhondt (ORCID: https://orcid.org/0000-0002-7954-5075)
- Hans Van Vlierberghe (ORCID: https://orcid.org/0000-0003-0647-9238)
- Sarah Raevens (ORCID: https://orcid.org/0000-0003-2810-7507)
- Lander Heyerick (ORCID: https://orcid.org/0000-0002-5314-0707)
Institutions
- Ghent University Hospital (BE)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.4254/wjh.v17.i2.102375
- Citations
- 1
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Universitair Ziekenhuis Gent
- Universiteit Gent